NCT04082286View on ClinicalTrials.gov

Yttrium-90 Anti CD66 Monoclonal Antibody in Childhood Relapsed/Refractory Leukaemia

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

May 14, 2020

Study Completion Date

May 14, 2020

Conditions
Acute Myeloblastic LeukemiaAcute Lymphoblastic LeukemiaJuvenile Myelomonocytic Leukemia
Interventions
OTHER

Yttrium-90 labelled monoclonal antibody against CD66

Trial Locations (1)

WC1N3JH

Great Ormond Street Hospital for Children, London

All Listed Sponsors
lead

Great Ormond Street Hospital for Children NHS Foundation Trust

OTHER

NCT04082286 - Yttrium-90 Anti CD66 Monoclonal Antibody in Childhood Relapsed/Refractory Leukaemia | Biotech Hunter | Biotech Hunter